Markets
News
Analysis
Tools
Learn
Stock
Score
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Will Starlink SPAC or IPO in 2025?
Key PointsThere are few private companies worth more than SpaceX, and many investors would like to own a piece of it.CEO Elon Musk has shown little interest in taking the rocket part of SpaceX public.However, Musk has been receptive to the idea of a spinoff and subsequent IPO of the Starlink satelli...
The Motley Fool
Wed, Aug 13
This Legacy Stock Is Back, Poised for a Major Rebound
Key PointsThe company is embracing its "Tar-zhay" positioning to focus on superior shopping experiences over rock-bottom prices.Target maintains industry-leading profit margins despite recent revenue challenges.The stock's 4.4% dividend yield is near historic highs and far above other retailer stock...
The Motley Fool
Wed, Aug 13
Aura Biosciences Posts Q2 Cash Surge
Key PointsMomentum in late-stage clinical development: pivotal Phase 3 CoMpass trial for bel-sar actively enrolling and over 240 patients had been pre-screened for the CoMpass trial as of Q2 2025, with completion targeted by end of 2025.Research and development expenses rose to $22.9 million for the...
The Motley Fool
Wed, Aug 13
Performance Food Sales Jump 12 Percent
Key PointsRevenue climbed 11.5% to $16.94 billion in Q4 FY2025, beating analyst expectations by $172 million.Adjusted diluted EPS (Non-GAAP) of $1.55 exceeded the $1.46 consensus.GAAP net income dropped 21.0% to $131.5 million primarily due to increased depreciation, amortization, and interest expen...
The Motley Fool
Wed, Aug 13
Compass Therapeutics dips after $120 mln equity offering
** Shares of biopharma firm Compass Therapeutics CMPX.O down 1.3% premarket to $3.13 after $120 mln follow-on priced ** Boston, Massachusetts-based oncology-focused CMPX late Tues announced 40 mln shares, including pre-funded warrants to buy ~6.7 mln shares ** Offering price of $3 is 5...
Reuters
Wed, Aug 13
Crown Crafts Sales Drop 4.5 Percent
Key PointsNet sales (GAAP) declined 4.5% to $15.5 million for Q1 FY2026, as the $2.1 million contribution from the Baby Boom acquisition was offset by declines in legacy product categories.Gross profit margin (GAAP) fell to 22.7% as tariffs on imports from China drove up costs.Net loss (GAAP) widene...
The Motley Fool
Wed, Aug 13
Street View: FDA nod for Insmed's lung disease drug is 'breath of fresh air'
** The U.S. Food and Drug Administration on Tuesday approved Insmed's INSM.O oral drug, Brinsupri, as the first treatment for non-cystic fibrosis bronchiectasis, a chronic lung disease marked by damaged airways, persistent cough and excess mucus production** At least 6 brokerages raised PT on th...
Reuters
Wed, Aug 13
Instil Bio Posts Wider Loss in Q2
Key PointsNon-GAAP earnings per share (EPS) for Q2 2025 were $(2.88), missing expectations by 15.2% compared to the $(2.50) estimate.Total research and development spending jumped 130.6% to $6.7 million (GAAP), reflecting higher pipeline investment compared to Q2 2024.Cash and investments declined t...
The Motley Fool
Wed, Aug 13
Investors react to 'messy' Q2 results from Hannover Re
By David BullAug 13 - (The Insurer) - Shares in Hannover Re were trading flat at midday on Wednesday after closing down 3.5% on Tuesday in response to what KBW analyst Darius Satkauskus described as a “messy quarter” for the reinsurer.On the company’s second-quarter earnings call yesterday, analysts...
Reuters
Wed, Aug 13
Palantir Technologies Stock: Will It Hit a $500 Billion Valuation This Year?
Key PointsPalantir's stock is rallying after another excellent quarter.The company's sales hit $1 billion in the second quarter and profits more than doubled.Its valuation has eclipsed that of many blue-chip stocks.10 stocks we like better than Palantir Technologies › Unstoppable -- that's the one w...
The Motley Fool
Wed, Aug 13
How Much Should Retirees Have Invested by Age 67?
Key PointsThe median U.S. household has saved just a fraction of the amount recommended for retirement.The stock market is a crucial tool everyone should use to varying degrees.Managing risk becomes a top priority as you age.The $23,760 Social Security bonus most retirees completely overlook › Every...
The Motley Fool
Wed, Aug 13
Perspective Therapeutics Reports Q2 Loss
Key PointsRevenue (GAAP) for Q2 2025 exceeded estimates by 47.1%, reaching $0.3 million due to continued NIH grant income.Net loss (GAAP) for Q2 2025 widened to $21.5 million, driven by a 79% surge in R&D expenses as clinical trials advanced.Management gave no formal guidance, but cash, cash equival...
The Motley Fool
Wed, Aug 13
Average UK motor premiums fall 9%: ABI
By Navneeta NandanAug 13 - (The Insurer) - The average cost of a UK motor insurance policy fell to 562 pounds ($761.90) in the second quarter of 2025, a drop of 60 pounds from the same period last year, according to the Association of British Insurers (ABI).UK motor insurers paid 3.1 billion pounds ...
Reuters
Wed, Aug 13
Comstock plunges after upsized $30 million stock sale
** Clean energy firm Comstock's LODE.A shares slide 18.2% to $2.47 premarket** LODE late Tuesday announced pricing of upsized $30 million stock offering** Virginia City-based LODE sold 13.3 million shares at $2.25 apiece, a 25.5% discount to stock's last close** Proceeds will be for commerci...
Reuters
Wed, Aug 13
Hudbay Minerals sells 30% stake in copper project to Mitsubishi for $600 million; shares rise
** U.S.-listed shares of copper miner Hudbay Minerals HBM.N, HBM.TO rise 12.7% to $11.10 premarket** Company sells 30% stake in copper project located in Arizona to Mitsubishi 8058.T for $600 million** The deal consists of $420 million in cash for 30% equity interest in the Copper World project at c...
Reuters
Wed, Aug 13
European Wax Center Sales Decline
Key PointsGAAP revenue for Q2 FY2025 missed expectations, declined 6.6% to $55.9 million versus the $56.89 million analyst forecast.Non-GAAP EPS for Q2 FY2025 met estimates at $0.16, while Adjusted EBITDA improved 4.7% to $21.6 million.Same-store sales growth was minimal at 0.3%, and the company rev...
The Motley Fool
Wed, Aug 13
4 Reasons to Buy PayPal Stock Like There's No Tomorrow
Key PointsThe fintech is focused on improving its offerings for small and medium-sized businesses.PayPal's other products, like Venmo and Buy Now Pay Later, have shown strong growth.Its stablecoin aims to reduce fees and improve cross-border transaction speeds.10 stocks we like better than PayPal › ...
The Motley Fool
Wed, Aug 13
Prediction: This Artificial Intelligence (AI) Stock Could Double by 2026
Key PointsSoundHound AI stock shot up after its latest report, thanks to its outstanding growth and improved guidance.The company's voice AI solutions are in hot demand, and its terrific growth pace has legs.Though the stock is expensive right now, it can justify its valuation because of its rapid g...
The Motley Fool
Wed, Aug 13
Europeans pile into local ETFs at record rate, at expense of US stocks
By Iain Withers LONDON, Aug 13 (Reuters) - European investors have put more money into local stock index-trackers so far in 2025 than in any full-year on record, with demand for defence funds booming, data shows, as President Donald Trump's erratic trade policy hits their appetite for U.S. sh...
Reuters
Wed, Aug 13
MORNING BID AMERICAS-Stocks soar, volatility evaporates
By Mike Dolan LONDON, Aug 13 (Reuters) - What matters in U.S. and global markets todayBy Mike Dolan, Editor-At-Large, Finance and Markets U.S. July inflation data didn't sound the all clear on tariffs but also didn’t send an unequivocal signal about the longer-term impacts either – and th...
Reuters
Wed, Aug 13
1
...
418
419
420
420
/
4137
421
422
...
4137
next page
KeyAI
Please log in to use KeyAI
Log in
Sign Up